Bone Biologics Financials - Benzinga

Bone Biologics Corp

BBLGNASDAQ

Trade with Public

Trade with Public

$0.6200

-0.0202-3.16%

Last update: Aug 20, 9:17 AM

Earnings: Q2 2026 Earnings were released on Fri Aug 14th, after the market close

Overview News Earnings Forecast EventsFinancialsSentiment Ownership Compare Stock Report

Bone Biologics Financials

Bone Biologics (BBLG) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Bone Biologics Q1 EPS $(0.43) Beats $(0.54) Estimate

Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.54) by 20.37 percent. This is a 77.6 percent increase over losses of $(1.92) per share from the

Benzinga Newsdesk

PRO
Bone Biologics Q2 EPS $(1.33) Misses $(0.58) Estimate

Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(0.58) by 129.31 percent. This is a 66.92 percent increase over losses of $(4.02) per share from

Benzinga Newsdesk

PRO
Bone Biologics Q1 EPS $(0.32) Beats $(0.48) Estimate

Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.48) by 33.33 percent. This is a 75.57 percent increase over losses of $(1.31) per share from

Benzinga Newsdesk

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September

Avi Kapoor

Nasdaq Surges 1%; Meta Posts Upbeat Earnings

Avi Kapoor

Nasdaq Down 2%; Alphabet Posts Upbeat Earnings

Avi Kapoor